COVID-19

September 3, 2021

Unvaccinated COVID-19 hospitalizations cost the U.S. health system billions of dollars | Comirnaty and PfizeSARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years | A third COVID-19 vaccine shot markedly boosts neutralizing antibody potency and breadth | Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting |.Virological characteristics of SARS-CoV-2 vaccine breakthrough infections in health care workers | COVID-19 Transmission Dynamics Among Close Contacts of Index Patients With COVID-19 | COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection

August 23, 2021

The SARS-CoV-2 Delta variant and its sublineages (B.1.617.2, AY.1, AY.2, AY.3; [1]) can cause high viral loads, are highly transmissible, and contain mutations that confer partial immune escape [2,3]. Using PCR threshold cycle (Ct) data from a single large contract laboratory, authors show that individuals in Wisconsin, USA had similar viral RNA loads in nasal swabs, irrespective of vaccine status, during a time of high and increasing prevalence of the Delta variant. Infectious SARS-CoV-2 was isolated from 51 of 55 specimens (93%) with Ct <25 from both vaccinated and unvaccinated persons, indicating that most individuals with Ct values in this range (Wilson 95% CI 83%-97%) shed infectious virus regardless of vaccine status. Notably, 68% of individuals infected despite vaccination tested positive with Ct <25, including at least 8 who were asymptomatic at the time of testing.

August 18, 2021

An Examination of School Reopening Strategies during the SARS-CoV-2 Pandemic | Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience | Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors

August 10, 2021

An Examination of School Reopening Strategies during the SARS-CoV-2 Pandemic | Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience | Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors

Teacher sitting at a table with students, all wearing masks.

August 2, 2021

SARS-CoV-2 Infection in Public School District Employees Following a District-Wide Vaccination Program — Philadelphia County, Pennsylvania, March 21–April 23, 2021 | More kids are being hospitalized for COVID, due to fewer masks, stagnating vaccination rates | Updated masking guidance from CDC

July 28, 2021

An Examination of School Reopening Strategies during the SARS-CoV-2 Pandemic | Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience | Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors

July 19, 2021

An Examination of School Reopening Strategies during the SARS-CoV-2 Pandemic | Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience | Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors

July 12, 2021

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 | The Impact of COVID Vaccination on Symptoms of Long COVID. An International Survey of People with Lived Experience of Long COVID | Ad26.COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of concern | Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines | Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial | Efficacy of Portable Air Cleaners and Masking for Reducing Indoor Exposure to Simulated Exhaled SARS-CoV-2 Aerosols — United States, 2021

July 6 2021

Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic | By Now, Burnout Is a Given | Confronting Our Next National Health Disaster — Long-Haul Covid | Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants |

A woman getting a vaccine

June 25, 2021

Efficacy and safety of azithromycin in Covid-19 patients: A systematic review and meta-analysis of randomized clinical trials
Azithromycin (AZM) is commonly used in Covid-19 patients based on low-quality evidence, increasing the risk of developing adverse events and antimicrobial resistance.

Parasites Without Borders

A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.

Donate to Parasites Without Borders today!

Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.

Scroll to Top